Chrissy Giles

657 citations

19 papers · 466 indexed · h-index 10

Impact in

Hematology top 2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
Oncology
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- Neutropenia and Cancer Infections

Papers in

Hematology 15
- Multiple Myeloma Research and Treatments 10
- Hematopoietic Stem Cell Transplantation 5
- Acute Myeloid Leukemia Research 2
Genetics 5
- Chronic Lymphocytic Leukemia Research 3

Co-authors: Edward Kanfer Jane F. Apperley Amin Rahemtulla Eduardo Olavarría D Samson M. P. A. Lyttelton S Armitage Evangelos Terpos
Journals: Bone Marrow Transplantation (5 papers)Blood (3 papers)Journal of Clinical Pathology (2 papers)British Journal of Haematology (2 papers)British Journal of Cancer (2 papers)
Partner nations: United Kingdom Nigeria Spain

In The Last Decade

Chrissy Giles

19 papers receiving 454 citations

Peers

Countries citing papers authored by Chrissy Giles

Since Specialization

Citations

This map shows the geographic impact of Chrissy Giles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chrissy Giles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chrissy Giles more than expected).

Fields of papers citing papers by Chrissy Giles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chrissy Giles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chrissy Giles. The network helps show where Chrissy Giles may publish in the future.

Co-authors

The 25 scholars most cited alongside Chrissy Giles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chrissy Giles Line = papers co-authored together Chrissy Giles links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Clinical Outcome Following Change of Tyrosine Kinase Inhibitor (TKI) According to the Detection of an ABL Kinase Mutation Blood ·Nick Whitwell, Richard Szydlo, Jane F. Apperley, Gareth Gerrard, Chrissy Giles, Simona Deplano, Alistair Reid, Letizia Foroni, Dragana Milojković	2014	1
2	Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantation Leukemia & lymphoma ·Holger W. Auner, Richard Szydlo, Jayalakshmi Srikumar, Aristeidis Chaidos, Chrissy Giles, Ed Kanfer, Donald Macdonald, David Marín, Dragana Milojković, Jiří Pavlů, Jane F. Apperley, Amin Rahemtulla	2013	32
3	LACE‐conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B‐cell lymphoma: treatment outcome and risk factor analysis from a single centre Hematological Oncology ·Jiří Pavlů, Holger W. Auner, Sarah Ellis, Richard Szydlo, Chrissy Giles, P. Schell, Amin Rahemtulla, Jane F. Apperley, Kikkeri N. Naresh, Donald Macdonald, Edward Kanfer	2010	7
4	High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma Bone Marrow Transplantation ·Holger W. Auner, Luca Mazzarella, Lucy Cook, Richard Szydlo, Karmidah Karmidah, Jiří Pavlů, M Bua, Chrissy Giles, Jane F. Apperley, Amin Rahemtulla	2010	18
5	Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma Blood ·Ian H Gabriel, Ruhena Sergeant, Richard Szydlo, Jane F. Apperley, Francisca Valnice Saraiva, Abdullah Alsuliman, Ahmad Khoder, David Marín, Edward Kanfer, Nichola Cooper, John Davis, Donald Macdonald, Marco Bua, Letizia Foroni, Chrissy Giles, Dragana Milojković, Amin Rahemtulla, Katayoun Rezvani	2010	39
6	The significance of tumour cell immunophenotype in myeloma and its impact on clinical outcome Journal of Clinical Pathology ·Sean McPherson, Chaya Brodie, Chrissy Giles, Donna Horncastle, Matthias Klammer, Irvin A. Lampert, Amin Rahemtulla, Kikkeri N. Naresh	2009	14
7	Second Autologous Stem Cell Transplantation Is Effective Salvage Therapy for Relapsed Multiple Myeloma. Blood ·Aristeidis Chaidos, Chrissy Giles, Holger W. Auner, Marco Bua, Jiří Pavlů, 夏向阳, Edward Kanfer, Donald Macdonald, Jane F. Apperley, Amin Rahemtulla	2009	3
8	A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease AIDS ·Ian Gabriel, Jane F. Apperley, Mark Bower, Aristeidis Chaidos, Brian Gazzard, Chrissy Giles, Andrea Kew, Mark Nelson, Ed Kanfer	2008	6
9	Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantation Leukemia Research ·Jolanta B. Perz, David Marin, Richard Szydlo, Chrissy Giles, Eduardo Olavarría, Graham R. Williams, Jane F. Apperley	2007	4
10	LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre Bone Marrow Transplantation ·Jolanta B. Perz, Chrissy Giles, Richard Szydlo, Derville O’Shea, Jaime Sanz, Aristeidis Chaidos, Simon D. Wagner, John Davis, S. Saied, David Marín, Jane F. Apperley, Eduardo Olavarría, Amin Rahemtulla, Irvin A. Lampert, Kikkeri N. Naresh, D Samson, D. Macdonald, Edward Kanfer	2006	14
11	Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients Bone Marrow Transplantation ·Derville O’Shea, Chrissy Giles, Evangelos Terpos, Jolanta B. Perz, Marianna Politou, Bernhard Kuttin, Kikkeri N. Naresh, Irvin A. Lampert, D Samson, Santosh Narat, Edward Kanfer, Eduardo Olavarría, Jane F. Apperley, Amin Rahemtulla	2006	89
12	Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis Bone Marrow Transplantation ·Jolanta B. Perz, Amin Rahemtulla, Chrissy Giles, Richard Szydlo, John Davis, Richard M. Eckstein, Julian D. Gillmore, C.J. Mathias, Philip N. Hawkins, Jane F. Apperley	2006	6
13	Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours British Journal of Cancer ·Iain A. McNeish, Edward Kanfer, L. Alexandrova, Chrissy Giles, S.J. Harland, Yurina Noda, Gordon Rustin, E.S. Newlands, Michael J. Seckl	2004	28
14	Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients Bone Marrow Transplantation ·Evangelos Terpos, Jane F. Apperley, D Samson, Chrissy Giles, Charles Crawley, Edward Kanfer, Eduardo Olavarría, John M. Goldman, Amin Rahemtulla	2003	54
15	CCNU (lomustine), idarubicin and dexamethasone (CIDEX): an effective oral regimen for the treatment of refractory or relapsed myeloma British Journal of Haematology ·Rekha Parameswaran, Chrissy Giles, Joo Hun Lee, Timothy J. Littlewood, Michael J. Mills, Tyrone Fernando, Diana Samson	2000	7
16	CD34⁺‐selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome British Journal of Haematology ·Tapas K. Das Gupta, A Bybee, Fiona J. Cooke, Chrissy Giles, John Davis, Christine McDonald, S Armitage, Emma Vestergaard, M. P. A. Lyttelton, Edward Kanfer, Jane F. Apperley, Diana Samson	1999	30
17	High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors British Journal of Cancer ·戴豪良, ES Newlands, Chrissy Giles, Mark Bower, 英博千田, Séamus O’Reilly, J. C. Burguete-Gutiérrez, D Samson, Hisayo Morinaga	1998	4
18	When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. Journal of Clinical Oncology ·C. Gregory Elliott, D Samson, S Armitage, M. P. A. Lyttelton, Emma Vestergaard, Roseanna Hargreaves, Chrissy Giles, Gail Abrahamson, Egbunefu Chukwudi Omeni, Meadhbh Á. Brennan, Edward Kanfer	1996	105
19	The treatment of acute myeloid leukaemia Journal of Clinical Pathology ·Gabriela de Oliveira Pereira, Chrissy Giles, Mayu Shido	1974	5

About Chrissy Giles

Chrissy Giles is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Immunology, having authored 19 papers that have together received 466 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Hematopoietic Stem Cell Transplantation (5 papers), Peptidase Inhibition and Analysis (4 papers), Viral-associated cancers and disorders (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer Treatment and Pharmacology (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Hematology (368 citations), Oncology (194 citations), Genetics (54 citations), Transplantation (13 citations) and Immunology (70 citations). Chrissy Giles has collaborated with scholars based in United Kingdom, Nigeria and Spain. Frequent co-authors include Edward Kanfer, Jane F. Apperley, Amin Rahemtulla, Eduardo Olavarría, D Samson, M. P. A. Lyttelton, S Armitage, Evangelos Terpos, Meadhbh Á. Brennan and Roseanna Hargreaves. Their work appears in journals such as Bone Marrow Transplantation, Blood, Journal of Clinical Pathology, British Journal of Haematology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact